• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部晚期无功能性胰腺神经内分泌肿瘤切除术后的预后因素:德国癌症研究协会德国肿瘤中心协会的分析。

Prognostic factors after resection of locally advanced non-functional pancreatic neuroendocrine neoplasm: an analysis from the German Cancer Registry Group of the Society of German Tumor Centers.

机构信息

Department of Surgery, University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23564, Lübeck, Germany.

Network for Care, Quality and Research in Oncology (ADT), German Cancer Registry Group of the Society of German Tumor Centers, Berlin, Germany.

出版信息

J Cancer Res Clin Oncol. 2023 Sep;149(11):8535-8543. doi: 10.1007/s00432-023-04785-0. Epub 2023 Apr 24.

DOI:10.1007/s00432-023-04785-0
PMID:37095413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10374814/
Abstract

OBJECTIVE

The available literature regarding outcome after pancreatic resection in locally advanced non-functional pNEN (LA-pNEN) is sparse. Therefore, this study evaluates the current survival outcomes and prognostic factors in after resection of LA-pNEN.

MATERIALS AND METHODS

This population-based analysis was derived from 17 German cancer registries from 2000 to 2019. Patients with upfront resected non-functional non-metastatic LA-pNEN were included.

RESULTS

Out of 2776 patients with pNEN, 277 met the inclusion criteria. 137 (45%) of the patients were female. The median age was 63 ± 18 years. Lymph node metastasis was present in 45%. G1, G2 and G3 pNEN were found in 39%, 47% and 14% of the patients, respectively. Resection of LA-pNEN resulted in favorable 3-, 5- and 10-year overall survival of 79%, 74%, and 47%. Positive resection margin was the only potentially modifiable independent prognostic factor for overall survival (HR 1.93, 95% CI 1.71-3.69, p value = 0.046), whereas tumor grade G3 (HR 5.26, 95% CI 2.09-13.25, p value < 0.001) and lymphangiosis (HR 2.35, 95% CI 1.20-4.59, p value = 0.012) were the only independent prognostic factors for disease-free survival.

CONCLUSION

Resection of LA-pNEN is feasible and associated with favorable overall survival. G1 LA-pNEN with negative resection margins and absence of lymph node metastasis and lymphangiosis might be considered as cured, while those not fulfilling these criteria might be considered as a high-risk group for disease progression. Herein, negative resection margins represent the only potentially modifiable prognostic factor in LA-pNEN but seem to be influenced by tumor grade.

摘要

目的

关于局部晚期非功能性胰腺神经内分泌肿瘤(LA-pNEN)切除术后的结果,相关文献较少。因此,本研究评估了 LA-pNEN 切除术后的当前生存结果和预后因素。

材料和方法

本基于人群的分析来自 2000 年至 2019 年的 17 个德国癌症登记处。纳入了接受初次切除的非转移性非功能性 LA-pNEN 患者。

结果

在 2776 名 pNEN 患者中,有 277 名符合纳入标准。137 名(45%)患者为女性。中位年龄为 63±18 岁。有 45%的患者存在淋巴结转移。G1、G2 和 G3 pNEN 分别在 39%、47%和 14%的患者中发现。LA-pNEN 的切除导致 3 年、5 年和 10 年的总生存率分别为 79%、74%和 47%。阳性切缘是唯一可能改变的独立总生存预后因素(HR 1.93,95%CI 1.71-3.69,p 值=0.046),而肿瘤分级 G3(HR 5.26,95%CI 2.09-13.25,p 值<0.001)和淋巴管浸润(HR 2.35,95%CI 1.20-4.59,p 值=0.012)是无病生存的唯一独立预后因素。

结论

LA-pNEN 的切除是可行的,与良好的总生存率相关。G1 LA-pNEN 且切缘阴性、无淋巴结转移和淋巴管浸润者可被认为是治愈的,而不符合这些标准的患者可能被认为是疾病进展的高危人群。在此,阴性切缘是 LA-pNEN 中唯一可能改变的预后因素,但似乎受肿瘤分级的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/637a/11797369/7786b80d2dfb/432_2023_4785_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/637a/11797369/a07c141bc12d/432_2023_4785_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/637a/11797369/6768041ecd22/432_2023_4785_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/637a/11797369/7786b80d2dfb/432_2023_4785_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/637a/11797369/a07c141bc12d/432_2023_4785_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/637a/11797369/6768041ecd22/432_2023_4785_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/637a/11797369/7786b80d2dfb/432_2023_4785_Fig3_HTML.jpg

相似文献

1
Prognostic factors after resection of locally advanced non-functional pancreatic neuroendocrine neoplasm: an analysis from the German Cancer Registry Group of the Society of German Tumor Centers.局部晚期无功能性胰腺神经内分泌肿瘤切除术后的预后因素:德国癌症研究协会德国肿瘤中心协会的分析。
J Cancer Res Clin Oncol. 2023 Sep;149(11):8535-8543. doi: 10.1007/s00432-023-04785-0. Epub 2023 Apr 24.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
Is the Thickness of the Margin Associated With Local Recurrence and Survival in Patients With Myxofibrosarcoma?黏液纤维肉瘤患者的边缘厚度与局部复发和生存有关吗?
Clin Orthop Relat Res. 2023 Nov 1;481(11):2125-2136. doi: 10.1097/CORR.0000000000002709. Epub 2023 May 29.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
6
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
7
What Are the Complications, Function, and Survival of Tumor-devitalized Autografts Used in Patients With Limb-sparing Surgery for Bone and Soft Tissue Tumors? A Japanese Musculoskeletal Oncology Group Multi-institutional Study.肿瘤灭活自体移植物用于保肢手术治疗骨和软组织肿瘤患者的并发症、功能和生存情况如何?日本肌肉骨骼肿瘤学组多机构研究。
Clin Orthop Relat Res. 2023 Nov 1;481(11):2110-2124. doi: 10.1097/CORR.0000000000002720. Epub 2023 Jun 14.
8
The Value of Infrapyloric Lymph Nodes Dissection in Right Hemicolectomy for Hepatic Flexure Colon Cancer: A Multicenter Analysis Based on Propensity Score Matching.幽门下淋巴结清扫在肝曲结肠癌右半结肠切除术中的价值:基于倾向评分匹配的多中心分析
Dis Colon Rectum. 2025 Mar 1;68(3):338-350. doi: 10.1097/DCR.0000000000003356. Epub 2024 Dec 18.
9
Oncological Outcomes of Intersphincteric Resection Versus Abdominoperineal Resection for ypT3 Low Rectal Cancer After Neoadjuvant Chemoradiotherapy: A Multicenter Retrospective Analysis.新辅助放化疗后ypT3期低位直肠癌行括约肌间切除术与腹会阴联合切除术的肿瘤学结局:一项多中心回顾性分析
Dis Colon Rectum. 2025 Aug 1;68(8):951-961. doi: 10.1097/DCR.0000000000003821. Epub 2025 May 7.
10
Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.老年新诊断胶质母细胞瘤的治疗:一项网状Meta分析
Cochrane Database Syst Rev. 2020 Mar 23;3(3):CD013261. doi: 10.1002/14651858.CD013261.pub2.

引用本文的文献

1
Impact of dyslipidemia and lipid-lowering therapy with statins in patients with neuroendocrine tumors.血脂异常及他汀类药物降脂治疗对神经内分泌肿瘤患者的影响。
J Neuroendocrinol. 2025 Feb;37(2):e13485. doi: 10.1111/jne.13485. Epub 2024 Dec 26.
2
Prognostic Nomograms for Patients With NF-Pan-NET After Pancreatectomy: A Retrospective Analysis Based on SEER Database.基于 SEER 数据库的胰腺切除术后 NF-Pan-NET 患者预后列线图:一项回顾性分析。
Cancer Rep (Hoboken). 2024 Sep;7(9):e2165. doi: 10.1002/cnr2.2165.
3
The extent of androgen receptor and HER2 expression allows for targeted therapy in most cases of salivary duct carcinoma: analysis of clinical and histopathological data in a tertiary care center.

本文引用的文献

1
Neoadjuvant PRRT for advanced pNEN: an unusual highlander.晚期胰腺神经内分泌肿瘤的新辅助肽受体放射性核素治疗:一个不寻常的“高地人”
Endocrine. 2021 Aug;73(2):493-495. doi: 10.1007/s12020-021-02662-9. Epub 2021 Mar 4.
2
Surgical Feasibility, Determinants, and Overall Efficacy of Neoadjuvant Lu-DOTATATE PRRT for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors.局部晚期不可切除胃肠胰神经内分泌肿瘤新辅助 Lu-DOTATATE PRRT 的手术可行性、决定因素和整体疗效。
J Nucl Med. 2021 Nov;62(11):1558-1563. doi: 10.2967/jnumed.120.258772. Epub 2021 Feb 26.
3
Portal vein resection during pancreaticoduodenectomy for pancreatic neuroendocrine tumors. An international multicenter comparative study.
雄激素受体和 HER2 表达的程度可使大多数唾液腺癌病例能够进行靶向治疗:在三级护理中心的临床和组织病理学数据分析。
Eur Arch Otorhinolaryngol. 2024 Jul;281(7):3779-3789. doi: 10.1007/s00405-024-08627-8. Epub 2024 Apr 8.
4
When Should Lymphadenectomy Be Performed in Non-Metastatic Pancreatic Neuroendocrine Tumors? A Population-Based Analysis of the German Clinical Cancer Registry Group.非转移性胰腺神经内分泌肿瘤何时应进行淋巴结清扫术?基于德国临床癌症登记组的人群分析。
Cancers (Basel). 2024 Jan 19;16(2):440. doi: 10.3390/cancers16020440.
5
Gastroenteropancreatic neuroendocrine carcinoma in children and adolescents: a population-based study.儿童和青少年胃肠胰神经内分泌癌:一项基于人群的研究。
J Cancer Res Clin Oncol. 2024 Jan 2;150(1):4. doi: 10.1007/s00432-023-05568-3.
6
Multivisceral resection of nonfunctional pancreatic neuroendocrine neoplasm with nearby organ invasion: a case report.多脏器切除术治疗伴有邻近器官侵犯的无功能胰腺神经内分泌肿瘤:病例报告。
Front Endocrinol (Lausanne). 2023 Sep 26;14:1236685. doi: 10.3389/fendo.2023.1236685. eCollection 2023.
7
[68/m-Satiety, increase in abdominal circumference, abdominal pain : Preparation for the medical specialist examination: part 45].[68岁男性——饱腹感、腹围增加、腹痛:医学专家考试备考:第45部分]
Chirurgie (Heidelb). 2023 Sep;94(Suppl 1):81-84. doi: 10.1007/s00104-023-01888-9. Epub 2023 May 26.
胰十二指肠切除术时门静脉切除治疗胰腺神经内分泌肿瘤:一项国际多中心对比研究。
Surgery. 2021 May;169(5):1093-1101. doi: 10.1016/j.surg.2020.11.015. Epub 2021 Jan 7.
4
Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.局部进展期胰腺神经内分泌肿瘤手术治疗效果评价。
JAMA Netw Open. 2020 Nov 2;3(11):e2024318. doi: 10.1001/jamanetworkopen.2020.24318.
5
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.胃肠胰神经内分泌肿瘤:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2020 Jul;31(7):844-860. doi: 10.1016/j.annonc.2020.03.304. Epub 2020 Apr 6.
6
Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors.卡培他滨/替莫唑胺新辅助治疗局部晚期或转移性胰腺神经内分泌肿瘤。
Pancreas. 2020 Mar;49(3):355-360. doi: 10.1097/MPA.0000000000001500.
7
The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors.北美神经内分泌肿瘤学会关于胰腺神经内分泌肿瘤手术治疗的共识文件。
Pancreas. 2020 Jan;49(1):1-33. doi: 10.1097/MPA.0000000000001454.
8
Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms.功能性和非功能性胰腺神经内分泌肿瘤的未满足需求。
Neuroendocrinology. 2019;108(1):26-36. doi: 10.1159/000494258. Epub 2018 Oct 3.
9
Tumor size classification of the 8 edition of TNM staging system is superior to that of the 7 edition in predicting the survival outcome of pancreatic cancer patients after radical resection and adjuvant chemotherapy.第八版 TNM 分期系统的肿瘤大小分类在预测胰腺癌患者根治性切除术后辅助化疗的生存结局方面优于第七版。
Sci Rep. 2018 Jul 10;8(1):10383. doi: 10.1038/s41598-018-28193-4.
10
Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors - a multi-institutional study.散发性切除的小(≤2厘米)无功能胰腺神经内分泌肿瘤的预后——一项多机构研究。
HPB (Oxford). 2018 Mar;20(3):251-259. doi: 10.1016/j.hpb.2017.08.034. Epub 2017 Oct 5.